| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia XS Puente, M Pinyol, V Quesada, L Conde, GR Ordóñez, N Villamor, ... Nature 475 (7354), 101-105, 2011 | 1875 | 2011 |
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia V Quesada, L Conde, N Villamor, GR Ordóñez, P Jares, L Bassaganyas, ... Nature genetics 44 (1), 47-52, 2012 | 1236 | 2012 |
| Non-coding recurrent mutations in chronic lymphocytic leukaemia XS Puente, S Beà, R Valdés-Mas, N Villamor, J Gutiérrez-Abril, ... Nature 526 (7574), 519-524, 2015 | 986 | 2015 |
| Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia F Nadeu, J Delgado, C Royo, T Baumann, T Stankovic, M Pinyol, P Jares, ... Blood, The Journal of the American Society of Hematology 127 (17), 2122-2130, 2016 | 365 | 2016 |
| NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome N Villamor, L Conde, A Martínez-Trillos, M Cazorla, A Navarro, S Bea, ... Leukemia 27 (5), 1100-1106, 2013 | 241 | 2013 |
| Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance C Moreno, K Hodgson, G Ferrer, M Elena, X Filella, A Pereira, T Baumann, ... Blood, The Journal of the American Society of Hematology 116 (23), 4771-4776, 2010 | 195 | 2010 |
| The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia R Beekman, V Chapaprieta, N Russiñol, R Vilarrasa-Blasi, ... Nature medicine 24 (6), 868-880, 2018 | 186 | 2018 |
| International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia A Condoluci, L Terzi di Bergamo, P Langerbeins, MA Hoechstetter, ... Blood, The Journal of the American Society of Hematology 135 (21), 1859-1869, 2020 | 129 | 2020 |
| Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different … J Delgado, M Doubek, T Baumann, J Kotaskova, S Molica, P Mozas, ... American journal of hematology 92 (4), 375-380, 2017 | 117 | 2017 |
| Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia F Nadeu, G Clot, J Delgado, D Martín-García, T Baumann, I Salaverria, ... Leukemia 32 (3), 645-653, 2018 | 108 | 2018 |
| Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: experience from an academic phase I clinical trial M Castella, M Caballero-Baños, V Ortiz-Maldonado, ... Frontiers in immunology 11, 482, 2020 | 107 | 2020 |
| CART19-BE-01: a multicenter trial of ARI-0001 cell therapy in patients with CD19+ relapsed/refractory malignancies V Ortíz-Maldonado, S Rives, M Castellà, A Alonso-Saladrigues, ... Molecular Therapy 29 (2), 636-644, 2021 | 101 | 2021 |
| Development of a novel anti-CD19 chimeric antigen receptor: a paradigm for an affordable CAR T cell production at academic institutions M Castella, A Boronat, R Martín-Ibáñez, V Rodríguez, G Suñé, ... Molecular Therapy-Methods & Clinical Development 12, 134-144, 2019 | 100 | 2019 |
| Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations C López, J Delgado, D Costa, L Conde, G Ghita, N Villamor, A Navarro, ... Genes, Chromosomes and Cancer 51 (9), 881-889, 2012 | 79 | 2012 |
| Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model T Baumann, J Delgado, R Santacruz, A Martínez-Trillos, C Royo, ... haematologica 99 (10), 1599, 2014 | 78 | 2014 |
| Genes encoding members of the JAK‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia C López, AK Bergmann, U Paul, EM Murga Penas, I Nagel, MJ Betts, ... British journal of haematology 173 (2), 265-273, 2016 | 77 | 2016 |
| Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era A Rivas‐Delgado, L Magnano, M Moreno‐Velázquez, O Garcia, F Nadeu, ... British journal of haematology 184 (5), 753-759, 2019 | 75 | 2019 |
| Detection of early seeding of Richter transformation in chronic lymphocytic leukemia F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ... Nature medicine 28 (8), 1662-1671, 2022 | 69 | 2022 |
| Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia D Rodríguez, G Bretones, V Quesada, N Villamor, JR Arango, ... Blood, The Journal of the American Society of Hematology 126 (2), 195-202, 2015 | 69 | 2015 |
| IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics F Nadeu, R Royo, G Clot, M Duran-Ferrer, A Navarro, S Martín, J Lu, ... Blood, The Journal of the American Society of Hematology 137 (21), 2935-2946, 2021 | 59 | 2021 |
Julio DelgadoHematology, Hospital Clínic, BarcelonaVerified email at clinic.cat
